Jesse Neri
Director Financiero/CFO en ROCKWELL MEDICAL, INC. .
Fortuna: 50 328 $ al 30/04/2024
Cargos activos de Jesse Neri
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ROCKWELL MEDICAL, INC. | Director Financiero/CFO | 18/10/2023 | - |
Historial de carrera de Jesse Neri
Antiguos cargos conocidos de Jesse Neri.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ZYLA LIFE SCIENCES | Corporate Officer/Principal | 01/06/2015 | - |
Formación de Jesse Neri.
| Villanova University | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 4 |
Operativa
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
| Director of Finance/CFO | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ROCKWELL MEDICAL, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Zyla Life Sciences LLC
 Zyla Life Sciences LLC Pharmaceuticals: MajorHealth Technology Zyla Life Sciences is a commercial-stage company, which focuses on developing, manufacturing and commercializing innovative treatments for pain. It is focused on bringing non-narcotic products and abuse-discouraging formulations of opioids to patients and healthcare providers. The company plans to continue to grow revenue of its seven commercial products, which includes Sprix nasal spray, Vivlodex, Zorvolex, Tivorbex, Indocin suppositories, Indocin oral suspension and oxaydo tablets, and explore business development opportunities. Zyla Life Sciences was founded in August 2013 and is headquartered in Wayne, PA. | Health Technology |
- Bolsa de valores
- Insiders
- Jesse Neri
- Experiencia